ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
70,378.02
0.35%
S&P 500
5,320.06
-0.03%
Dow Jones
39,830.37
-0.11%
US Dollar vs Yen
156.4925
0.15%
Brent Oil
82.205
-0.29%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Neuronetics Inc (STIM)

  7. Neuronetics Inc (STIM) ニュース

STIM

Neuronetics (STIM)

Neuronetics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:STIM
日付受信時刻ニュースソース見出しコード企業名
2024/05/1520 : 32GlobeNewswire Inc.Humana Is First Commercial Payer to Address TMS Therapy Coverage for AdolescentsNASDAQ:STIMNeuronetics Inc
2024/05/0805 : 31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STIMNeuronetics Inc
2024/05/0720 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
2024/05/0720 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
2024/05/0720 : 30GlobeNewswire Inc.Neuronetics Reports Record First Quarter 2024 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
2024/05/0405 : 30GlobeNewswire Inc.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:STIMNeuronetics Inc
2024/05/0121 : 31GlobeNewswire Inc.NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness MonthNASDAQ:STIMNeuronetics Inc
2024/04/2405 : 30GlobeNewswire Inc.Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference CallNASDAQ:STIMNeuronetics Inc
2024/04/1021 : 31GlobeNewswire Inc.New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is VitalNASDAQ:STIMNeuronetics Inc
2024/03/2805 : 30GlobeNewswire Inc.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:STIMNeuronetics Inc
2024/03/2521 : 30GlobeNewswire Inc.NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with DepressionNASDAQ:STIMNeuronetics Inc
2024/03/0722 : 22GlobeNewswire Inc.Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care NetworkNASDAQ:STIMNeuronetics Inc
2024/03/0706 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
2024/03/0521 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
2024/03/0521 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
2024/03/0521 : 30GlobeNewswire Inc.Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
2024/03/0207 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
2024/03/0207 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
2024/03/0107 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
2024/03/0106 : 10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
2024/02/2907 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
2024/02/2906 : 48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
2024/02/2906 : 16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
2024/02/2807 : 33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
2024/02/2707 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
2024/02/2706 : 54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
2024/02/2406 : 23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
2024/02/2307 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
2024/02/2306 : 14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
2024/02/2105 : 19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
 Showing the most relevant articles for your search:NASDAQ:STIM

最近閲覧した銘柄

BIT
USIG
Liquid In Grade Corp Bon...
NASDAQ
FYJSKX
Virtual Economy Portfoli...
EU
MLPER
Perseida Renta Gestion S...
TSXV
VLT
Volt Lithium
NASDAQ
NK
NantKwest
LSE
66JG
Arkle 1ma
NASDAQ
MAQCU
Maquia Capital Acquisition
NASDAQ
FTIQX
Federated Hermes Short T...
COIN
GMATUST
GoWithMi
USOTC
FSHRF
Feishang Anthracite Reso... (PK)
KOSPI
006345
Dawon Cable
AMEX
TPHD
Timothy Plan High Divide...
CSE
YY
Yellow Stem Tech
NASDAQ
TLACX
Transamerica Large Core ...
NYSE
ARP-E
NYSE
MGB
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有